Clinical Trial Update: Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a closed-loop insulin delivery approach with reduced meal bolusing over 36 hours in adolescents with Type 1 diabetes has completed. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Cambridge | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED